C07D - Heterocyclic compounds

More topics under "C07D - Heterocyclic compounds" (1,537,440)
C07D 201 - Preparation, separation, purification, or stabilisation of unsubstituted lactams (2,192)
C07D 203 - Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom (1,097)
C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868)
C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120)
C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
C07D 225 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom (1,649)
C07D 227 - Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups (473)
C07D 229 - Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms (515)
C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
C07D 245 - Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms (898)
C07D 247 - Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups (239)
C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
C07D 251 - Heterocyclic compounds containing 1,3,5-triazine rings (10,913)
C07D 253 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group (2,967)
C07D 255 - Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups (739)
C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
C07D 259 - Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms (488)
C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms (2,022)
C07D 269 - Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups (111)
C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
C07D 273 - Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups (2,368)
C07D 275 - Heterocyclic compounds containing 1, 2-thiazole or hydrogenated 1,2-thiazole rings (4,972)
C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149)
C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924)
C07D 283 - Heterocyclic compounds containing rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms, according to more than one of groups (102)
C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
C07D 291 - Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms (1,087)
C07D 293 - Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms (553)
C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
C07D 301 - Preparation of oxiranes (10,136)
C07D 303 - Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom (12,512)
C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442)
C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580)
C07D 315 - Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups (1,360)
C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
C07D 321 - Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups (2,079)
C07D 323 - Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms (1,581)
C07D 325 - Heterocyclic compounds containing rings having oxygen as the only ring hetero atom according to more than one of groups (168)
C07D 327 - Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms (2,428)
C07D 329 - Heterocyclic compounds containing rings having oxygen and selenium or oxygen and tellurium atoms as the only ring hetero atoms (47)
C07D 331 - Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom (456)
C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725)
C07D 337 - Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom (875)
C07D 339 - Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms (3,352)
C07D 341 - Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms (281)
C07D 343 - Heterocyclic compounds containing rings having sulfur and selenium or sulfur and tellurium atoms as the only ring hetero atoms (52)
C07D 345 - Heterocyclic compounds containing rings having selenium or tellurium atoms as the only ring hetero atoms (419)
C07D 347 - Heterocyclic compounds containing rings having halogen atoms as ring hetero atoms (38)
C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465)
C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
C07D 415 - Heterocyclic compounds containing the thiamine skeleton (90)
C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
C07D 419 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms (1,431)
C07D 421 - Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms (480)
C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
C07D 455 - Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine (2,122)
C07D 457 - Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula: , e.g. lysergic acid (836)
C07D 459 - Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems, e.g. yohimbine; 16, 18-lactones thereof, e.g. reserpic acid lactone (97)
C07D 461 - Heterocyclic compounds containing indolo [3, 2, 1-d, e] pyrido [3, 2, 1-i, j] [1, 5]-naphthyridine ring systems, e.g. vincamine (286)
C07D 463 - Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (613)
C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718)
C07D 477 - Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (2,484)
C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
C07D 489 - Heterocyclic compounds containing 4ah-8, 9 c- iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: (2,334)
C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
C07D 497 - Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms (1,069)
C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
C07D 499 - Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (3,448)
C07D 501 - Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (7,574)
C07D 503 - Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (648)
C07D 505 - Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (556)
C07D 507 - Heterocyclic compounds containing a condensed beta-lactam ring system, not provided for by groups , or; Such ring systems being further condensed (161)
C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
C07D 515 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (877)
C07D 517 - Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms (452)
C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)

Patents for C07D - Heterocyclic compounds (10,420)
12/1998
12/03/1998	WO1998054157A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p561ck TYROSINE KINASES
12/03/1998	WO1998054156A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR P56lck TYROSINE KINASES
12/03/1998	WO1998053711A1 Dehydration plant
12/03/1998	CA2291774A1 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
12/03/1998	CA2291750A1 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
12/03/1998	CA2291728A1 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
12/01/1998	US5843966 Piperidine derivatives
11/1998
11/24/1998	CA2108584C Substituted azetidinones as anti-inflammatory and antidegenerative agents
11/19/1998	WO1998051685A1 Method of manufacturing sertindole
11/18/1998	EP0757669B1 O-acyl-4-phenyl-cyclohexanols, their salts, medicaments containing such compounds and their use, as well as a method of preparing them
11/18/1998	CN1040756C Heterocyclic compounds preparation process
11/18/1998	CN1040749C Process for preparation of phenoxypyrimidine compounds
11/17/1998	US5837707 Dimeric piperidine, tetrahydropyridine and piperazine derivatives
11/12/1998	CA2289001A1 Novel heterocyclic compounds
11/11/1998	EP0720609B1 3-(5-tetrazolyl-benzyl)amino-piperidine derivatives and antagonists of tachykinins
11/10/1998	US5834502 Triazolylmethyl-indole ethylamine bisulfate salt
11/05/1998	WO1998049138A2 Vitamin d3 analogs with bis c-20 side chains
11/05/1998	WO1998048628A1 Composition for controlling harmful bio-organisms and method for controlling harmful bio-organisms using the same
11/05/1998	CA2706631A1 Composition for controlling harmful bio-organisms and method for controlling harmful bio-organisms using the same
11/04/1998	EP0874830A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation
11/04/1998	CN1040504C Process for preparation of pharmaceutical composition containing triazole derivative
11/03/1998	US5830896 Psychological disorders; antiepilepic agents; alzheimer'sand parkinson?s disease
10/1998
10/28/1998	EP0873326A1 Process for preparing 2-chlorothiazole compounds
10/28/1998	EP0873321A1 Novel amido quinoxaline diones, their production and use
10/28/1998	CN1040441C Process for prepn. of 3-exomethylenecepham derivatives
10/27/1998	US5827871 Medicaments 1,2,3,4-tetrahydrocarbazoles and 5-HT1 agonist use thereof
10/27/1998	CA2102179C Quinuclidine derivatives
10/22/1998	WO1998046243A2 Pharmaceutical compositions having appetite suppressant activity
10/22/1998	CA2584411A1 Pharmaceutical compositions having appetite suppressant activity
10/21/1998	EP0872478A2 Intermediates for the preparation of 1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
10/21/1998	EP0872237A1 Method and compositions for the synthesis of BCH-189 and related compounds
10/21/1998	EP0871625A1 Preparation of triazoles by organometallic addition to ketones and intermediates therefor
10/21/1998	EP0871623A1 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists
10/21/1998	CN1040321C Pyran-2-ones and 5,6-dihydropyran-2-ones, medicine composition containing them and pharmacy use thereof
10/14/1998	EP0869966A1 Prodrugs of thrombin inhibitors
10/14/1998	EP0869958A1 Novel indole-2,3-dione-3-oxime derivatives
10/13/1998	US5821363 Antineoplastic use and pharmaceutical compositions containing them
10/07/1998	EP0649424B1 Dioxcyclobutene derivatives as angiotensin ii antagonists
10/07/1998	CN1195353A New inhibitors of platelet aggregation
10/07/1998	CN1195346A Preparation of triazoles by organometallic addition to ketones and intermediates therefor
10/07/1998	CN1195289A Pharmaceutical compositions
10/01/1998	WO1998042705A1 Salt of naphthyridine carboxylic acid derivative
10/01/1998	WO1998042675A1 Substituted isoquinolines as ultra short acting neuromuscular blockers
10/01/1998	WO1998042674A1 Substituted isoquinolines as ultra short acting neuromuscular blockers
09/1998
09/30/1998	CN1039996C N-substituted azabicycloheptane devivatives and its use
09/29/1998	US5814652 Pesticidal 5-amino-4-ethylsulfinyl-1-arylpyrazoles
09/29/1998	US5814648 N-hydroxyureas as antiinflammatory agents
09/29/1998	US5814639 Treating aids
09/23/1998	EP0865431A2 Compounds
09/23/1998	CN1193961A Substituted benzylaminopiperidine compounds
09/23/1998	CN1039908C Tricyclic diazepine vasopressin antagonists
09/22/1998	US5811441 Inhibition of platelet aggregation; treatment of autoimmune diseases
09/22/1998	CA2093221C N-sulfonylindoline derivatives carrying an amide functional group, their preparation, and the pharmaceutical compositions in which they are present
09/17/1998	WO1998040366A1 Saccharine-5-carbonyl-cyclohexane-1,3,5-trione derivatives, their preparation and their use as herbicides
09/17/1998	WO1998040331A1 Preparation of preparing substituted indanones
09/17/1998	CA2283491A1 Saccharine-5-carbonyl-cyclohexane-1,3,5-trione derivatives, their preparation and their use as herbicides
09/16/1998	EP0804421B1 Use of 2- (dihydro)pyrazolyl-3'-oxymethylene]-anilides as pest-control agents and fungicides
09/16/1998	CN1039771C Composition containing sulfurylareas compounds and its herbicidal usage
09/15/1998	US5807867 Quinuclidine derivatives
09/11/1998	WO1998039322A1 Method for preparing 2-thienylethylamine derivatives
09/09/1998	EP0862555A1 Substituted aryl or heteroarylamides having retinoid-like biological activity
09/09/1998	EP0591280B1 Use of tetrahydrocarbazole derivatives as 5ht1-receptor agonists
09/09/1998	EP0513200B1 Method and compositions for the synthesis of bch-189 and related compounds
09/03/1998	WO1998038174A1 Pyrazine compounds
09/03/1998	WO1998008855A3 N6 heterocyclic substituted adenosine derivatives
09/02/1998	EP0861248A1 Indolealkyl derivatives of benzodioxanmethylamine as 5-ht1a receptor ligands
09/02/1998	EP0861235A1 Substituted benzylaminopiperidine compounds
09/01/1998	US5801179 Treatment of migraines, hypotension, venous insufficiency
08/1998
08/27/1998	WO1998037073A1 Process for the preparation of substituted thiazolidinedione
08/26/1998	CN1191488A Use of calendula glycosides for treatment of psoriasis
08/26/1998	CN1191111A Process for preparing pharmaceutical composition containing N-acyl-2,3-benzodiazepine derivatives as active ingredient
08/25/1998	CA2084867C Mouthwash compositions
08/25/1998	CA2071193C Sulfonamides
08/20/1998	WO1998035963A1 Process for preparing eprosartan
08/19/1998	EP0858451A1 Pharmaceutically active quinazoline compounds
08/19/1998	CN1190957A Form III crystalline (R-(R,R)-2-(4-fluorophenyl)-beta-delta-dihydroxy-5-(1-methyl-ethyl)-3-phenyl-4-((phenylamino) carbonyl)-1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin)
08/19/1998	CN1190955A Crystalline £R-(R',R')\|-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(5-methylethyl)-3-phenyl-4-(phenylamino) carbonyl\|-1H-pyrole-1-heptanoic acid hemi calcium salt (atorvastatin)
08/18/1998	CA2089906C Naphthalene derivatives, processes for preparing the same, and synthetic intermediates therefor
08/13/1998	WO1998034934A1 Amino acid ester containing azole antifungals
08/12/1998	CN1039492C Carboxyl-substituted nitrogen heterocyclic ring and its preparation intermediate composition and application
08/11/1998	US5792790 Method for improving weight gain and feed utilization in livestock
08/11/1998	US5792777 Biphenyl quinuclidines
08/11/1998	US5792644 DNA encoding an Eimeria 200 kd antigen
08/06/1998	WO1998033782A1 Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent
08/06/1998	WO1998016507A3 New heterocyclylmethyl-substituted pyrazol derivates and their use for treating cardiovascular diseases
08/05/1998	EP0649407B1 Dimeric piperidine, tetrahydropyridine and piperazine derivatives
08/05/1998	CN1189496A New physical form of artemisinin and its use in production of pharmaceuticals
08/05/1998	CN1189490A Process for preparing 1-biphenylmethylimidazole derivatives
08/05/1998	CN1039416C Process for preparing novel pyrido (3,2-B) (1.5) benzothiazepines
08/04/1998	US5789421 Fibrinogen receptor antagonist
08/04/1998	US5789416 Cardiovascular and nervous system disorders
08/04/1998	US5789233 Amino acid sequence that selectively binds with antibody; for preparation of a vector vaccine against coccidiosis.
07/1998
07/30/1998	WO1998023565A3 Aminoguanidines and alkoxyguanidines as protease inhibitors
07/29/1998	EP0854874A1 Macrocyclic lactone compounds and their production process
07/29/1998	EP0854867A1 Tetrahydroquinolines as nmda antagonists
07/29/1998	CN1189152A Process for producing of enantiomerically-pure azetidein-2-carboxylic acid
07/29/1998	CN1189148A 1, 3-propane diol derivatives as bioactive compounds
07/29/1998	CN1188645A Process for preparing pharmaceutical composition for treatment or prevention hypertension
07/29/1998	CN1039322C Preparation method of indole derivatives
07/28/1998	CA2127561C 3-azabicyclohexane compound intermediates for producing antibacterial compounds

1 ... 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 ... 105